PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Carcinoma Breast Stage IV
Interventions: DRUG: Combination of trastuzumab and PS-341
Sponsor: Jules Bordet Institute